Illustration depicting the impact of heroin use on kidney health, highlighting the link to secondary amyloidosis.

The Hidden Threat: How Heroin Use Can Lead to a Rare Kidney Disease

Author's portrait.
Elliot Brynn in Health & Wellness December 2025 • 5 min read.

"Unveiling the Link Between Heroin, Infections, and Secondary Amyloidosis"


In a world grappling with the opioid epidemic, the devastating effects of heroin use extend far beyond the immediate dangers of overdose. Emerging research reveals a hidden threat: the potential for long-term health complications, including a rare but serious kidney disease called secondary amyloidosis. This condition, often triggered by chronic infections, can significantly impact the lives of those struggling with substance abuse.

Secondary amyloidosis is a condition where abnormal proteins accumulate in various organs, leading to organ damage and dysfunction. While it can arise from various underlying causes, chronic infections, particularly those common among individuals who use intravenous drugs, are a significant trigger. This article aims to shed light on this lesser-known consequence of heroin use, highlighting the risks and emphasizing the importance of awareness and early intervention.

Understanding the link between heroin use, recurrent infections, and secondary amyloidosis is crucial for both individuals struggling with addiction and healthcare professionals. By raising awareness, we can improve early detection, promote effective treatment, and ultimately, save lives. This article will delve into the details of this condition, providing valuable insights into its causes, symptoms, and the steps that can be taken to mitigate its impact.

Unraveling Secondary Amyloidosis: The Culprit and Its Consequences

Illustration depicting the impact of heroin use on kidney health, highlighting the link to secondary amyloidosis.

Secondary amyloidosis (AA amyloidosis) is a condition characterized by the buildup of abnormal proteins called amyloid fibrils in various organs and tissues. These fibrils are formed from a protein called serum amyloid A (SAA), which is produced in the liver during periods of inflammation. Chronic inflammation, often stemming from persistent infections, is a major driver of AA amyloidosis.

Heroin use, particularly through intravenous injection, increases the risk of infections. Skin infections, such as abscesses, and infections of the heart valves (endocarditis) are common among people who inject drugs. These infections trigger the body's inflammatory response, leading to the overproduction of SAA. Over time, this can result in the deposition of amyloid fibrils in organs like the kidneys, liver, spleen, and heart, causing damage and dysfunction.

  • Kidney Damage: The kidneys are the most commonly affected organs, leading to proteinuria (protein in the urine) and kidney failure.
  • Liver and Spleen Enlargement: Amyloid deposits can cause these organs to enlarge, disrupting their normal function.
  • Heart Problems: Amyloidosis can lead to heart failure and arrhythmias.
  • Gastrointestinal Issues: The digestive system may be affected, leading to malabsorption, diarrhea, and bleeding.
  • Neuropathy: Nerve damage can occur, causing pain, numbness, and weakness.
The insidious nature of secondary amyloidosis lies in its often-silent progression. Symptoms may be vague initially, making early detection challenging. However, as the condition worsens, individuals may experience fatigue, swelling, and signs of organ dysfunction. Diagnosis typically involves blood and urine tests, along with imaging and, in some cases, a biopsy to identify the amyloid deposits.

Taking Action: Prevention, Treatment, and Support

Addressing the link between heroin use and secondary amyloidosis requires a multi-faceted approach. Prevention efforts should focus on reducing the risk of substance abuse through education, access to treatment, and harm reduction strategies. Early detection through routine screenings and awareness among healthcare providers is crucial. Treatment involves managing the underlying infections, suppressing inflammation, and providing supportive care for organ damage. Furthermore, individuals struggling with addiction need access to comprehensive treatment programs, including medication-assisted treatment and behavioral therapies. By working together, we can mitigate the devastating consequences of heroin use and protect the health and well-being of those affected.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

1

How does heroin use increase the risk of developing secondary amyloidosis?

Heroin use, especially intravenous injection, elevates the risk of infections like skin abscesses and endocarditis. These infections trigger an inflammatory response, leading to the overproduction of serum amyloid A (SAA) in the liver. Over time, the continuous overproduction of SAA can result in the deposition of amyloid fibrils in organs such as the kidneys, liver, spleen and heart, causing damage and dysfunction characteristic of secondary amyloidosis.

2

What exactly is secondary amyloidosis (AA amyloidosis), and what role does serum amyloid A (SAA) play in its development?

Secondary amyloidosis, also known as AA amyloidosis, is a condition marked by the accumulation of abnormal protein deposits called amyloid fibrils in various organs and tissues. These fibrils are derived from serum amyloid A (SAA), a protein produced by the liver during inflammatory responses. In cases of chronic inflammation, persistent infections trigger continuous SAA production. The persistent overproduction leads to the accumulation of amyloid fibrils, causing organ damage and dysfunction in secondary amyloidosis.

3

What are the primary organs affected by secondary amyloidosis, and what specific problems can arise in each?

The kidneys are the most commonly affected organs in secondary amyloidosis, leading to proteinuria and kidney failure. Amyloid deposits can also cause enlargement of the liver and spleen, disrupting their normal functions. The heart can be affected, potentially leading to heart failure and arrhythmias. Furthermore, the gastrointestinal system might suffer from malabsorption, diarrhea, and bleeding, while nerve damage can result in neuropathy, causing pain, numbness, and weakness.

4

Besides managing infections, what treatment options are available for individuals diagnosed with secondary amyloidosis resulting from heroin use?

Beyond addressing the underlying infections, treatment for secondary amyloidosis involves suppressing inflammation and providing supportive care for organ damage. Comprehensive addiction treatment programs, including medication-assisted treatment and behavioral therapies, are crucial for individuals struggling with heroin addiction. Managing inflammation can help reduce the production of serum amyloid A (SAA), preventing further amyloid fibril buildup. Supportive care aims to alleviate symptoms and improve the function of affected organs.

5

Given the connection between heroin use, infections, and secondary amyloidosis, what preventative measures and harm reduction strategies can be implemented to mitigate the risk of developing this kidney disease?

To mitigate the risk of secondary amyloidosis, prevention efforts should focus on reducing substance abuse through education, access to treatment, and harm reduction strategies. Early detection through routine screenings and increased awareness among healthcare providers is also crucial. Individuals who inject drugs should be educated about safe injection practices to minimize the risk of infections. Access to clean needles and syringes, along with proper wound care, can help prevent skin infections and endocarditis, reducing the inflammatory response and subsequent overproduction of serum amyloid A (SAA).

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.